Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Carl Zeiss A/S
A/S
Active
CVR 84786217
Bregnerødvej 133, 3460
Birkerød
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1979 · 47 years old
42 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Carl Zeiss A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
192M
144M
96M
48M
0M
2021: 127M
127M
2021
2022: 130M (+2% vs 2021)
130M
+2%
2022
2023: 154M (+18% vs 2022)
154M
+18%
2023
2024: 154M (0% vs 2023)
154M
0%
2024
2025: 131M (-15% vs 2024)
131M
-15%
2025
EBITDA
DKK millions
11M
8M
6M
3M
0M
2021: 9M
9M
2021
2022: 8M (-11% vs 2021)
8M
-11%
2022
2023: 7M (-12% vs 2022)
7M
-12%
2023
2024: 9M (+29% vs 2023)
9M
+29%
2024
2025: 8M (-11% vs 2024)
8M
-11%
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Revenue
130.735
153.638
154.119
130.091
126.673
Staff expenses
-34.003
-31.954
-29.013
-28.846
-28.580
EBITDA
8.362
9.496
7.360
8.492
9.091
Depreciation & amort.
-1.853
-2.279
-1.782
-1.226
-1.319
EBIT
6.509
7.217
5.578
7.266
7.772
Net financials
38
128
-85
-1
2.723
Profit before tax
6.547
7.345
5.493
7.265
10.495
Tax
1.455
1.608
1.129
1.607
1.637
Net profit
5.092
5.737
4.364
5.658
8.858
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
57.605
65.118
73.031
65.366
54.495
Equity
18.865
23.773
20.436
25.476
27.554
Long-term debt
0
0
0
0
0
Short-term debt
37.811
39.755
50.736
38.170
25.399
Total debt
37.811
39.755
50.736
38.170
25.399
Financial ratios
5-year trend
EBITDA margin
6,4 %
This company
15,8 %
Market median
This company
Market median
59% below market
2021
2025
Equity ratio
32,7 %
This company
38,2 %
Market median
This company
Market median
14% below market
2021
2025
Return on equity
27,0 %
This company
18,4 %
Market median
This company
Market median
47% above market
2021
2025
Net profit margin
3,9 %
This company
8,1 %
Market median
This company
Market median
52% below market
2021
2025
Asset turnover
2,27×
This company
1,12×
Market median
This company
Market median
103% above market
2021
2025
Debt / equity
2,05×
This company
0,62×
Market median
This company
Market median
231% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
View
PDF
More on Carl Zeiss A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
